AG˹ٷ

STOCK TITAN

[8-K] DocGo Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Form 4 filing: On 06/20/2025 Evolv Technologies Holdings, Inc. (EVLV) reported that Director Kimberly H. Sheehy received 27,050 Restricted Stock Units (RSUs). Each RSU converts into one share of Class A common stock and carries no exercise price.

The RSUs vest in full on the earlier of 06/20/2026 or the day immediately preceding the company’s next annual meeting, promoting near-term board alignment. No shares were sold or disposed of, and the entire award is held directly by the reporting person. After the grant, Sheehy beneficially owns 27,050 derivative securities tied to EVLV shares.

This appears to be a routine director compensation grant. While it slightly increases potential share count, the dilution effect is minimal. Nonetheless, the award strengthens the director’s economic stake, which investors may view as a modestly positive governance signal.

Deposito del Modulo 4: Il 20/06/2025 Evolv Technologies Holdings, Inc. (EVLV) ha comunicato che la Direttrice Kimberly H. Sheehy ha ricevuto 27.050 Unità Azionarie Vincolate (RSU). Ogni RSU si converte in una azione ordinaria di Classe A senza prezzo di esercizio.

Le RSU maturano completamente il prima tra il 20/06/2026 o il giorno precedente la prossima assemblea annuale della società, favorendo un allineamento a breve termine del consiglio. Nessuna azione è stata venduta o ceduta, e l’intero premio è detenuto direttamente dalla persona che ha effettuato la segnalazione. Dopo l’assegnazione, Sheehy possiede beneficiariamente 27.050 strumenti derivati legati alle azioni EVLV.

Si tratta apparentemente di un premio di compensazione ordinario per i direttori. Sebbene aumenti leggermente il numero potenziale di azioni, l’effetto diluitivo è minimo. Tuttavia, il premio rafforza la partecipazione economica della direttrice, un segnale di governance che gli investitori potrebbero considerare moderatamente positivo.

Presentación del Formulario 4: El 20/06/2025 Evolv Technologies Holdings, Inc. (EVLV) informó que la Directora Kimberly H. Sheehy recibió 27,050 Unidades de Acciones Restringidas (RSU). Cada RSU se convierte en una acción común Clase A sin precio de ejercicio.

Las RSU vencen completamente en la fecha que ocurra primero, ya sea el 20/06/2026 o el día anterior a la próxima junta anual de la compañía, promoviendo una alineación cercana en el consejo. No se vendieron ni dispusieron acciones, y todo el premio está en manos directas de la persona que reporta. Tras la concesión, Sheehy posee beneficiosamente 27,050 valores derivados vinculados a acciones de EVLV.

Esto parece ser una concesión rutinaria de compensación para directores. Aunque incrementa ligeramente el número potencial de acciones, el efecto dilutivo es mínimo. No obstante, el premio fortalece la participación económica de la directora, lo que los inversores podrían interpretar como una señal de gobernanza modestamente positiva.

� 4 신고: 2025� 6� 20�, Evolv Technologies Holdings, Inc. (EVLV)� 이사 Kimberly H. Sheehy가 27,050개의 제한 주식 단위(RSU)� 받았다고 보고했습니다. � RSU� 클래� A 보통� 1주로 전환되며 행사 가격이 없습니다.

RSU� 회사� 다음 연례 회의 전날 또는 2026� 6� 20� � 빠른 날짜� 전액 베스�되어 단기 이사� 정렬� 촉진합니�. 주식은 매도되거� 처분되지 않았으며, 전체 보상은 신고인에 의해 직Ϊ 보유되고 있습니다. 부� � Sheehy� EVLV 주식� 연계� 27,050개의 파생 증권� 실질적으� 소유하고 있습니다.

이는 일상적인 이사 보상 부�� 보입니다. 잠재� 주식 수는 약간 증가하지� 희석 효과� 미미합니�. 그럼에도 불구하고 � 보상은 이사� 경제� 지분을 강화하며, 투자자들은 이를 다소 긍정적인 거버넌스 신호� � � 있습니다.

Dépôt du formulaire 4 : Le 20/06/2025, Evolv Technologies Holdings, Inc. (EVLV) a annoncé que la directrice Kimberly H. Sheehy a reçu 27 050 unités d’actions restreintes (RSU). Chaque RSU se convertit en une action ordinaire de classe A sans prix d’exercice.

Les RSU deviennent pleinement acquises à la date la plus proche entre le 20/06/2026 ou la veille de la prochaine assemblée annuelle de la société, favorisant un alignement à court terme du conseil d’administration. Aucune action n’a été vendue ou cédée, et la totalité de la récompense est détenue directement par la personne déclarant. Après l’attribution, Sheehy détient effectivement 27 050 titres dérivés liés aux actions EVLV.

Il semble s’agir d’une attribution de rémunération habituelle pour un administrateur. Bien que cela augmente légèrement le nombre potentiel d’actions, l’effet dilutif est minime. Néanmoins, cette attribution renforce la participation économique de la directrice, ce que les investisseurs peuvent percevoir comme un signal de gouvernance modérément positif.

Formular 4 Einreichung: Am 20.06.2025 berichtete Evolv Technologies Holdings, Inc. (EVLV), dass Direktorin Kimberly H. Sheehy 27.050 Restricted Stock Units (RSUs) erhalten hat. Jede RSU wandelt sich in eine Aktie der Klasse A um und hat keinen Ausübungspreis.

Die RSUs werden vollständig am früheren der beiden Termine 20.06.2026 oder dem Tag vor der nächsten Hauptversammlung des Unternehmens fällig, was eine kurzfristige Ausrichtung des Vorstands fördert. Es wurden keine Aktien verkauft oder veräußert, und die gesamte Zuteilung wird direkt von der meldenden Person gehalten. Nach der Zuteilung besitzt Sheehy wirtschaftlich 27.050 derivative Wertpapiere, die an EVLV-Aktien gebunden sind.

Dies scheint eine übliche Vergütung für Direktoren zu sein. Obwohl die potenzielle Aktienanzahl leicht erhöht wird, ist der Verwässerungseffekt minimal. Dennoch stärkt die Zuteilung das wirtschaftliche Interesse der Direktorin, was Investoren als ein moderat positives Governance-Signal werten könnten.

Positive
  • 27,050 RSUs granted to a board member, modestly improving alignment between director and shareholders at no cash cost to the company.
Negative
  • Minor potential dilution once the RSUs convert to shares, though impact is expected to be negligible.

Insights

TL;DR: Routine RSU grant to director; negligible dilution, modest alignment benefit, no immediate valuation impact.

The filing discloses a standard equity award�27,050 RSUs—to Director Kimberly Sheehy. No cash paid, no sales reported. Such grants are common in board compensation packages and do not signal insider buying enthusiasm. Because the shares are unvested and represent a very small fraction of EVLV’s equity, the transaction is unlikely to move the stock. Investors may view the award as modestly positive for alignment, but overall impact is neutral.

TL;DR: Equity award enhances board-shareholder alignment; standard practice, low governance risk.

Granting RSUs that vest within a year ties director compensation to share performance without immediate cash outlay. The single-year vest improves retention and encourages focus on near-term corporate objectives. Because the award size is limited and disclosure is timely, the filing presents no red flags. There are no Rule 10b5-1 sales, amendments, or accelerated vesting clauses that might concern investors. I classify the event as routine and not materially impactful.

Deposito del Modulo 4: Il 20/06/2025 Evolv Technologies Holdings, Inc. (EVLV) ha comunicato che la Direttrice Kimberly H. Sheehy ha ricevuto 27.050 Unità Azionarie Vincolate (RSU). Ogni RSU si converte in una azione ordinaria di Classe A senza prezzo di esercizio.

Le RSU maturano completamente il prima tra il 20/06/2026 o il giorno precedente la prossima assemblea annuale della società, favorendo un allineamento a breve termine del consiglio. Nessuna azione è stata venduta o ceduta, e l’intero premio è detenuto direttamente dalla persona che ha effettuato la segnalazione. Dopo l’assegnazione, Sheehy possiede beneficiariamente 27.050 strumenti derivati legati alle azioni EVLV.

Si tratta apparentemente di un premio di compensazione ordinario per i direttori. Sebbene aumenti leggermente il numero potenziale di azioni, l’effetto diluitivo è minimo. Tuttavia, il premio rafforza la partecipazione economica della direttrice, un segnale di governance che gli investitori potrebbero considerare moderatamente positivo.

Presentación del Formulario 4: El 20/06/2025 Evolv Technologies Holdings, Inc. (EVLV) informó que la Directora Kimberly H. Sheehy recibió 27,050 Unidades de Acciones Restringidas (RSU). Cada RSU se convierte en una acción común Clase A sin precio de ejercicio.

Las RSU vencen completamente en la fecha que ocurra primero, ya sea el 20/06/2026 o el día anterior a la próxima junta anual de la compañía, promoviendo una alineación cercana en el consejo. No se vendieron ni dispusieron acciones, y todo el premio está en manos directas de la persona que reporta. Tras la concesión, Sheehy posee beneficiosamente 27,050 valores derivados vinculados a acciones de EVLV.

Esto parece ser una concesión rutinaria de compensación para directores. Aunque incrementa ligeramente el número potencial de acciones, el efecto dilutivo es mínimo. No obstante, el premio fortalece la participación económica de la directora, lo que los inversores podrían interpretar como una señal de gobernanza modestamente positiva.

� 4 신고: 2025� 6� 20�, Evolv Technologies Holdings, Inc. (EVLV)� 이사 Kimberly H. Sheehy가 27,050개의 제한 주식 단위(RSU)� 받았다고 보고했습니다. � RSU� 클래� A 보통� 1주로 전환되며 행사 가격이 없습니다.

RSU� 회사� 다음 연례 회의 전날 또는 2026� 6� 20� � 빠른 날짜� 전액 베스�되어 단기 이사� 정렬� 촉진합니�. 주식은 매도되거� 처분되지 않았으며, 전체 보상은 신고인에 의해 직Ϊ 보유되고 있습니다. 부� � Sheehy� EVLV 주식� 연계� 27,050개의 파생 증권� 실질적으� 소유하고 있습니다.

이는 일상적인 이사 보상 부�� 보입니다. 잠재� 주식 수는 약간 증가하지� 희석 효과� 미미합니�. 그럼에도 불구하고 � 보상은 이사� 경제� 지분을 강화하며, 투자자들은 이를 다소 긍정적인 거버넌스 신호� � � 있습니다.

Dépôt du formulaire 4 : Le 20/06/2025, Evolv Technologies Holdings, Inc. (EVLV) a annoncé que la directrice Kimberly H. Sheehy a reçu 27 050 unités d’actions restreintes (RSU). Chaque RSU se convertit en une action ordinaire de classe A sans prix d’exercice.

Les RSU deviennent pleinement acquises à la date la plus proche entre le 20/06/2026 ou la veille de la prochaine assemblée annuelle de la société, favorisant un alignement à court terme du conseil d’administration. Aucune action n’a été vendue ou cédée, et la totalité de la récompense est détenue directement par la personne déclarant. Après l’attribution, Sheehy détient effectivement 27 050 titres dérivés liés aux actions EVLV.

Il semble s’agir d’une attribution de rémunération habituelle pour un administrateur. Bien que cela augmente légèrement le nombre potentiel d’actions, l’effet dilutif est minime. Néanmoins, cette attribution renforce la participation économique de la directrice, ce que les investisseurs peuvent percevoir comme un signal de gouvernance modérément positif.

Formular 4 Einreichung: Am 20.06.2025 berichtete Evolv Technologies Holdings, Inc. (EVLV), dass Direktorin Kimberly H. Sheehy 27.050 Restricted Stock Units (RSUs) erhalten hat. Jede RSU wandelt sich in eine Aktie der Klasse A um und hat keinen Ausübungspreis.

Die RSUs werden vollständig am früheren der beiden Termine 20.06.2026 oder dem Tag vor der nächsten Hauptversammlung des Unternehmens fällig, was eine kurzfristige Ausrichtung des Vorstands fördert. Es wurden keine Aktien verkauft oder veräußert, und die gesamte Zuteilung wird direkt von der meldenden Person gehalten. Nach der Zuteilung besitzt Sheehy wirtschaftlich 27.050 derivative Wertpapiere, die an EVLV-Aktien gebunden sind.

Dies scheint eine übliche Vergütung für Direktoren zu sein. Obwohl die potenzielle Aktienanzahl leicht erhöht wird, ist der Verwässerungseffekt minimal. Dennoch stärkt die Zuteilung das wirtschaftliche Interesse der Direktorin, was Investoren als ein moderat positives Governance-Signal werten könnten.

0001822359FALSE00018223592025-06-172025-06-17


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________

FORM 8-K
___________________________________

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): June 17, 2025
___________________________________

DOCGO INC.
(Exact name of registrant as specified in its charter)
___________________________________

Delaware
001-39618
85-2515483
(State or other jurisdiction of incorporation or organization)(Commission File Number)(I.R.S. Employer Identification No.)
685 Third Avenue, 9th Floor, New York, New York
10017
(Address of principal executive offices)
(Zip Code)
(844) 443-6246
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
___________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Common stock, par value $0.0001 per shareDCGOThe Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 17, 2025, DocGo Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”) at 12:00 p.m. Eastern Time. As of the close of business on April 21, 2025, the record date for the Annual Meeting, there were 99,104,331 shares of common stock entitled to vote at the Annual Meeting. The results of the matters voted upon at the Annual Meeting were as follows:

1.Election of the three Class I director nominees to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified:

Director NomineeVotes ForVotes WithheldBroker Non-Votes
Lee Bienstock57,200,3349,753,60014,816,506
Ely D. Tendler50,676,00016,277,93414,816,506
Ira Smedra43,889,91323,064,02114,816,506

Pursuant to the foregoing votes, the three nominees listed above were elected to serve on the Company’s Board of Directors. There were no additional director nominations brought before the Annual Meeting.

2.To approve on a non-binding, advisory basis the compensation of the Company’s named executive officers:

Votes ForVotes AgainstAbstentionsBroker Non-Votes
47,948,09018,150,345855,49914,816,506

Pursuant to the foregoing vote, the stockholders approved on a non-binding, advisory basis the compensation of the Company’s named executive officers.

3.To approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation (the “Charter”) regarding the waiver of corporate opportunities (the “Corporate Opportunity Amendment”):

Votes ForVotes AgainstAbstentionsBroker Non-Votes
63,657,3922,135,0291,161,51314,816,506

Pursuant to the foregoing vote, the stockholders did not approve the Corporate Opportunity Amendment.

4.To approve an amendment to the Charter to limit the liability of certain officers as permitted by Delaware law (the “Officer Exculpation Amendment”):

Votes ForVotes AgainstAbstentionsBroker Non-Votes
59,968,6216,190,586794,72714,816,506

Pursuant to the foregoing vote, the stockholders did not approve the Officer Exculpation Amendment.

5.Ratification of the appointment of Urish Popeck & Co., LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2025:
Votes ForVotes AgainstAbstentionsBroker Non-Votes
76,704,1154,814,668251,657

Pursuant to the foregoing vote, the stockholders ratified the appointment of Urish Popeck & Co., LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2025.


1


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


DOCGO INC.
By:
/s/ Ely D. Tendler
Name:
Ely D. Tendler
Title:
General Counsel and Secretary

Date: June 18, 2025


2

FAQ

How many EVLV shares were awarded to Director Kimberly Sheehy in the Form 4?

She received 27,050 Restricted Stock Units, each convertible into one Class A share.

When do the RSUs reported by EVLV vest?

They vest in full on 06/20/2026 or the day before the next annual meeting, whichever comes first.

Were any EVLV shares sold in this Form 4 filing?

No shares were sold or disposed of; the filing only reports an RSU grant.

What is the exercise price of the RSUs granted to the director?

The RSUs carry a $0 exercise price.

Does this Form 4 indicate a change in the director’s ownership form?

The RSUs are held directly by Kimberly Sheehy; no indirect holdings were reported.
DOCGO INC

NASDAQ:DCGO

DCGO Rankings

DCGO Latest News

DCGO Latest SEC Filings

DCGO Stock Data

140.73M
92.05M
8.83%
52.43%
7.56%
Medical Care Facilities
Services-health Services
United States
NEW YORK